SFT Årsmöte 2013

Vetenskapligt program: Risk assessment – Learning from pharmacological toxicology

Läs mer

SFT Årsmöte 2013
Fredag 22 mars 2013
kl 8.45 – ca 16.00

Nobel Forum
Nobels väg 1,
Karolinska Institutet, Solna.
Visa på karta

  • Kaffe/Te och smörgås serveras från kl 08.45.
  • Det vetenskapliga programmet(på engelska) pågår mellan 09.30 och ca 13.30.
  • Därefter årsmötesförhandlingar och information om ERT och SweTox(13.30 – ca 16.00).

Detta år är det högaktuella temat för det vetenskapliga programmet: Riskassessment: Learning from pharmacological toxicology

Drug toxicity remains a high profile issue at a time when the recent publicized controversies surrounding the safety of some drugs have contributed to a public perception that the drug safety system is in crisis.

The SFT annual meeting 2013 will be dedicated to the potential of new biology and technology to contribute to the development of predictive strategies for the risk assessment and use of safe drugs. The presentations will describe and discuss the complex and multidisciplinary science of drug safety assessment that shares the principles with other branches of toxicology.

After lunch, the new initiative to form the Swedish Toxicology Sciences Institute (SweTox) will be presented and open for discussion.

We would like the SFT annual meeting to be the number one arena for toxicological networking and informal cross-sector contacts. Please take the opportunity to meet your new and old friends and colleagues during lunch and coffee breaks.

Vetenskapligt Program:

9:30-9:45 Opening of the meeting,
Dr Mattias Öberg, President of the Swedish SOT (SFTs ordförande)

9:45-10:20 Basic principles of the safety assessment of drugs,
Dr Björn Dahl, AstraZeneca
SFT2013, Björn Dahl (pdf)

10:20-11:10 The use and impact of novel technologies for risk
assessment of pharmaceuticals,
In silico modeling, stem cells and multidimensional in vitro models
Professor Ian Cotgreave, AstraZeneca
SFT2013, Ian Cotgreave (pdf)

The application of safety biomarkers to risk assessment of drugs,
Dr Ina Schuppe Koistinen, Science for Life Laboratory /
AstraZeneca Translational Science Centre
SFT2013, Ina Schuppe Koistinen (pdf)

11:10-11.35 What is the predictive value of cancer studies?
Dr Anna-Lena Berg, Medical Products Acency

11:35 – 12:00 Current regulatory discussion on carcinogenitcity testing of pharmaceuticals,
Dr Ulla Wändel-Liminga, Medical Products Acency

12:00 – 13:00 Lunch

13:00-13:30 How can contemperary toxicology and safety/risk assessment learn from and fertilize drug development,
Panel discussion

13:30-14:00 Årsmötesförhandlingar(in Swedish)

14:00 – 14:30 Coffee

14:30-14:50 ERT, European Registered Toxicologist (in Swedish)
Charlotte Nilsson, Marie Haag Grönlund
SFT2013, Charlotte Nilsson och Marie Haag Grönlund (pdf)

14:50-16:00 Swedish Toxicology Sciences Institute, SweTox(in Swedish)
SweTox project group

Vetenskapligt program, Årsmötesförhandlingar, mm:

Program 2013 (pdf)
Agenda för årsmötesförhandlingar 2013 (pdf)
Verksamhetsberättelse 2012 (pdf)
Årsmötesprotokoll 2013 (pdf)